{"id":538551,"date":"2021-09-15T08:33:36","date_gmt":"2021-09-15T12:33:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/"},"modified":"2021-09-15T08:33:36","modified_gmt":"2021-09-15T12:33:36","slug":"reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/","title":{"rendered":"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CUPERTINO, Calif., Sept.  15, 2021  (GLOBE NEWSWIRE) &#8212; Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (\u201cReviva\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Benzinga Healthcare Small Cap Conference as well as participate in one-on-one meetings with investors. The Conference will be held virtually with all participants joining remotely on September 29<sup>th<\/sup>-30<sup>th<\/sup>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em><br \/>\n            <u>Benzinga Healthcare Small Cap Conference <\/u><br \/>\n          <\/em><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Date: Wednesday, September 29, 2021<br \/>Time: 1:55 \u2013 2:15 pm ET <br \/>Speaker: Laxminarayan Bhat, Ph.D., <em>Chief Executive Officer<\/em><br \/>Webcast: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EBzkwolcLiYyb0-2wMgYuE5Gn5f2i8k6UjgdxbnilkY3cnWNazjJfHmjSUr5kNH2orabZwTincijTrEpE_tnAv_nzx_TPnB0lzfBtDmLv_jcHb1M-5xXxhVpCi38SJ0lsTmP8nLpgcbRlkuLjT8pdlo8MKyL7PiH-k91RBxna-zfpEaDXPNi_cJOdTd8XA3yv3r0XZH41rwMgQhsTvigGu1sPospEe2AlWeUlv-lzeg=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/september-29-track-1\/<\/a><\/p>\n<p align=\"justify\">A link to the live audio webcast as well as the replay of the webcast will be available on Reviva\u2019s website, under the \u201cInvestors- News &amp; Events\u201d section at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EBzkwolcLiYyb0-2wMgYuGcgQm8m3UtRCOuf7Q8llkAHJXVZijO_bkH4aZ0qk0FxEEYz55YZB6LNgbUAqeZykzebRbT9m3REnoQ7GJ9xAs4=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.revivapharma.com<\/a>.<\/p>\n<p align=\"justify\">For more information about the Benzinga Healthcare Small Cap Conference, please visit the Benzinga conference website. If you are interested in arranging a virtual one-on-one meeting, please contact the Company via the online registration found at the link below <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EBzkwolcLiYyb0-2wMgYuE5Gn5f2i8k6UjgdxbnilkY3cnWNazjJfHmjSUr5kNH2aHY1lb2UQIV5fi703tzRpyCD-6uf28PGhx1K7jdCiqDmK5K3VRyzk_Mfw4BT-57PQQlefEd2twKhpJkeDPvXBicUdd0W1aoEyyqm8ePmuxA=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/<\/a>.<\/p>\n<p>\n        <strong>About Reviva <\/strong>\n      <\/p>\n<p align=\"justify\">Reviva is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva\u2019s current pipeline focuses on the central nervous system, respiratory and metabolic diseases. Reviva\u2019s pipeline currently includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both RP5063 and R1208 in the United States (U.S.), Europe, and several other countries.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act, as amended, including those relating to the Company\u2019s product development, clinical and regulatory timelines and expenses, market opportunity, ability to raise sufficient funding, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management\u2019s current beliefs and assumptions.<\/p>\n<p align=\"justify\">These statements may be identified by the use of forward-looking expressions, including, but not limited to, \u201cexpect,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpotential, \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201cwould\u201d and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company\u2019s filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.<\/p>\n<p>\n        <strong>Corporate Contact:<\/strong><br \/>\n        <br \/>Reviva Pharmaceuticals Holdings, Inc.<br \/>Laxminarayan Bhat, PhD <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B8lJpuEExV90sJlm06Lx7LEiSlq1bTWIqPmiOyLVGcDvAjdcU5zD6-YlprRqa8RuySfGC902hkoRYPWmhypUujwjcT3ml_I3m8OM5GcKfZM=\" rel=\"nofollow noopener\" target=\"_blank\">www.revivapharma.com<\/a><\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>LifeSci Advisors, LLC<br \/>Bruce Mackle<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZRioz3CTkLQSdo2XgjLhHlvcLefoW9P-MhtTglUBktVfBiyh8o_xI-jwl0IADGqlrmm3nvUUxxuAvEa2934N7vKjTnUI6EWQzX1fOZlnzdAzusDL5r7L8DIdyQsmwZZc\" rel=\"nofollow noopener\" target=\"_blank\">bmackle@lifesciadvisors.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MDFlZmQxNDUtMzE2OS00NGM3LTliNTAtZWQ5ZTM2ZjQ0OGU3LTUwMDA3NTM4MQ==\/tiny\/Reviva-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CUPERTINO, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (\u201cReviva\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Benzinga Healthcare Small Cap Conference as well as participate in one-on-one meetings with investors. The Conference will be held virtually with all participants joining remotely on September 29th-30th. Benzinga Healthcare Small Cap Conference Date: Wednesday, September 29, 2021Time: 1:55 \u2013 2:15 pm ET Speaker: Laxminarayan Bhat, Ph.D., Chief Executive OfficerWebcast: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/september-29-track-1\/ A link to the live audio webcast as well &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-538551","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CUPERTINO, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (\u201cReviva\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Benzinga Healthcare Small Cap Conference as well as participate in one-on-one meetings with investors. The Conference will be held virtually with all participants joining remotely on September 29th-30th. Benzinga Healthcare Small Cap Conference Date: Wednesday, September 29, 2021Time: 1:55 \u2013 2:15 pm ET Speaker: Laxminarayan Bhat, Ph.D., Chief Executive OfficerWebcast: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/september-29-track-1\/ A link to the live audio webcast as well &hellip; Continue reading &quot;Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-15T12:33:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference\",\"datePublished\":\"2021-09-15T12:33:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/\"},\"wordCount\":574,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/\",\"name\":\"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==\",\"datePublished\":\"2021-09-15T12:33:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/","og_locale":"en_US","og_type":"article","og_title":"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference - Market Newsdesk","og_description":"CUPERTINO, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (\u201cReviva\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Benzinga Healthcare Small Cap Conference as well as participate in one-on-one meetings with investors. The Conference will be held virtually with all participants joining remotely on September 29th-30th. Benzinga Healthcare Small Cap Conference Date: Wednesday, September 29, 2021Time: 1:55 \u2013 2:15 pm ET Speaker: Laxminarayan Bhat, Ph.D., Chief Executive OfficerWebcast: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/september-29-track-1\/ A link to the live audio webcast as well &hellip; Continue reading \"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-15T12:33:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference","datePublished":"2021-09-15T12:33:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/"},"wordCount":574,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/","name":"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==","datePublished":"2021-09-15T12:33:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTA5NCM0NDAyNzA0IzUwMDA3NTM4MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reviva-pharmaceuticals-to-present-at-the-upcoming-benzinga-healthcare-small-cap-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Reviva Pharmaceuticals to Present at the Upcoming\u00a0Benzinga Healthcare Small Cap Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=538551"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538551\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=538551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=538551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=538551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}